Let's try this:- We have been told the new production capacity...

Let's try this:

- We have been told the new production capacity is capable of 350L every three months

- From the ppt the administered dose rate is 14 micrograms per 0.5ml solution (zoom in on the front cover ingredients)

- So we now have a production rate of 700,000 units per three months (350L / 0.5 ml)

- At a cost of 50 GBP which averages close to AUD 75 per dose

- Revenue is $ 52.5 M for every production of 350L

- At and average of 12 doses per ulcer for treatment this is only 58,000 ulcers treated (0.185 % of the numbers nosie has quoted as the 31.5M ulcers annually)

- Let say each person has two ulcers then TIS's three months production can only treat 29,000 people

IMO people will be lining up just to get in the queue as this does not service a lot of people.

- Let's say TIS get their 30% profit. This equates to $17.5 M per three months or $ 63 M profit per year. Depending upon your expected ratios the company's MC should be trading somewhere between $500M and $1B.

IMO TIS need to start to plan for a larger production unit or duplicate the current setup maybe perhaps in Europe.

Please DYOR as the above numbers are a simpletons view of the information provided by different mechanisms and is likely to have errors. :)